Abstract. The BTB-kelch protein Nd1-L acts as an actin cytoskeleton stabilizer expressed ubiquitously in mouse tissues. We examined the effect of Nd1-L on cancer cell invasion and metastasis. Over-expression of Nd1-L in murine colon carcinoma cell line Colon 26 and murine melanoma cell line B16 resulted in suppression of pulmonary and liver metastasis after inoculation of these cells to syngeneric mice and in increased survival in an animal model. On the other hand, knock down of Nd1-L by RNA interference promoted metastasis ability of these cells. Increased expression of Nd1-L inhibited migration and Matrigel invasion capacity of cancer cell lines in vitro. Thus, Nd1-L expression inversely correlated with invasive and metastasis capacity of cancer cells. Furthermore, increased expression of Nd1-L in NIH3T3 cells inhibited growth factor induced activation of Rho family small GTPases such as Rho, Rac and cdc42. These results suggest that Nd1-L is involved in invasion and metastasis of cancer cells by regulating the actin cytoskeleton and Rho family proteins.
Introduction
The kelch family proteins contain 4-7 kelch motifs that form a propeller-like structure (1) . In addition to the kelch motifs, the majority of the kelch proteins contain a BTB/POZ domain (broad complex, tramtrack and brick a brac/Pox virus and zinc finger) that mediates protein-protein interactions (2) . Bioinformatics analysis identified at least 71 kelch proteins in the human and mouse genome, which reveals that the kelch motif is widely distributed (3) . Many kelch domaincontaining proteins interact with actin and are important mediators of fundamental cellular functions, such as regulation of cellular architecture, cellular organization, and cell migration (4) (5) (6) . More recently, it has been suggested that the kelch repeats may also bind to proteins other than actin. It has also been shown that some BTB-kelch proteins serve as a substratespecific adaptor for cullin 3 ubiquitin ligases (7) (8) (9) . Nd1-L contains a BTB/POZ domain in its N terminus and six kelch repeats in the C terminus (10) . In NIH3T3 cells, Nd1-L colocalized with actin filaments in stress fibers and stabilized actin cytoskeleton (10) . Overexpression of Nd1-L in the heart of transgenic mice protected the cardiomyocyte apoptosis and improved a survival rate after doxorubicin injection (11) . Furthermore, study of Nd1-L knockout mice revealed that Nd1-L plays a protective role in doxorubicin-induced cardiotoxic responses (12) .
It has been shown that some BTB-kelch proteins play important roles in cancer. For example, point mutations of Keap1, which induce loss of its function, exist in lung cancer (13) . Mutations in the neuronal nuclear matrix protein NRPB/ ENC1 were observed in brain tumors (14, 15) . In addition, the kelch motif-containing protein Mayven was abundant and diffuse in primary human epithelial breast tumor cells as compared to normal breast epithelial cells, where Mayven was detected in the normal breast layer of the mammary ducts (16) . Metastasis is the most life-threatening complication of cancer and major problem of cancer treatment. Tumor cell migration and invasion are essential steps for establishment of cancer metastasis (17) . It is well known that the actin cytoskeleton is a major component of the cell motility machinery. Changes in actin cytoskeleton organization, adhesiveness and motility are important not only for tumor development and progression but also may be critical for determining invasion and metastasis potential of tumor cells (18, 19) . However, the molecular mechanisms underlying the invasion and metastasis of tumor cells are not well understood. Genomewide screening of genes responsible for virulence of cancer cells or metastatic ability has been performed using primary cancer cells or cancer cell lines (20) (21) (22) . Genes encoding actin-binding protein, matrix metalloproteinase, chemokine and chemokine receptors or adhesion molecules were listed as candidate genes (22) .
In this study, we examined the effect of Nd1-L on invasion, metastasis and virulence of cancer cells using murine colon carcinoma cells and murine melanoma cells. Here we show that Nd1-L functions as a metastasis suppressor in in vivo animal model. Amount of Nd1-L in these cancer cells inversely correlated with invasion and metastatic ability in vitro and in vivo. Furthermore, Rho family small GTPases activity was inhibited by over-expression of Nd1-L in NIH 3T3 cells. We also discuss the role of Nd1-L in cancer cell invasion and metastasis.
Materials and methods
Cell culture. NIH3T3 cells and B16 murine melanoma cells were maintained in Dulbecco's modified Eagle's medium (Sigma) supplemented with 10% fetal bovine serum (Sigma) at 37˚C, 5% CO 2 . Colon 26 murine colon adenocarcinoma cells were maintained in RPMI (Sigma) supplemented with 10% fetal bovine serum (Sigma) (23) . In some experiments, lysophosphatidic acid (LPA) (Sigma) or PDGF-BB (Pepro Tech Inc.) was added in the culture medium.
Construction of FLAG epitope-tagged Nd1-L expression plasmid (pCR-2FLAG-Nd1-L).
Flag-Nd1-L expression plasmids (pCR-2FLAG-Nd1-L) were constructed by PCR amplifying Nd1-L fragments containing an open reading frame and ligating them to EcoRI site of pCR-2FLAG (10).
Construction of Nd1-L RNA interference plasmid (pBAsiNd1-L).
A short interfering RNA (siRNA)-cording oligo against Kelch motif of Nd1-L was designed and verified to be specific for Nd1-L by a Blast search done against the mouse genome. The Nd1-L/siRNA-targeting sequence is 5'-GTCTACAACCCTCAGTCAA-3'. The U6 promoter with Nd1-L/siRNA was cloned into a commercially available vector pBAsi-mU6 Neo (Takara) to make pBAsi-Nd1-L. A siRNA oligo used as a negative control is 5'-GACTTCGTCA CGTAGTAAC-3'. 6 cells/10 cm dish) were plated 24 h before transfection. Cells were transfected with 3.0 μg/60 mm dish or 15 μg/10 cm dish of pCR3.1-2FLAG-Nd1-L or pBAsi-Nd1-L using TransFast™ Transfection Reagent (Promega) and harvested after 48 h. To establish stable transfectants, NIH3T3 cells and Colon 26 cells were selected with 500 μg/ml G418 and B16 cells with 800 μg/ml G418.
Experimental metastasis. C57BL/6 Cr.Slc and BALB/c mice were purchased from Japan SLC Co. (Hamamatsu, Japan). The care of all animals used in the present study was in accordance with Chiba University Animal Care guidelines.
B16 cells were briefly trypsinized and suspended in PBS. Cells (1.0x10 6 ) were injected into the lateral tail vein of 6-7-week old female C57BL/6 mice in a volume of 0.2 ml. At 2 weeks after i.v. injection, mice were sacrificed and the lungs were extirpated and the black spherical B16 metastatic nodules were counted.
Colon 26 cells were briefly trypsinized and suspended in PBS. Cells (1.0x10 5 ) were injected into the tail veins of 6-7-week old female BALB/c mice. At 2 weeks after i.v. injection, mice were sacrificed and the lungs were extirpated and white Colon 26 metastatic nodules were counted. In order to reveal white metastatic nodules markedly, indocyanine green dye (ICG) (2.5 mg/ml) was injected into trachea in a volume of 1.0 ml to stain the lungs.
For liver metastasis experiments, cells were injected into the spleen of the mice and splenectomies were performed 5 min after intrasplenic injection. Ten days after inoculation, mice were sacrificed and liver metastasis were analyzed by measuring liver weights as described previously (24) .
Measurement of primary tumor growth. Cells were harvested by trypsinization, suspended in PBS and counted. Cells (1.0x10 6 ) were injected subcutaneously at the abdomen in a volume of 0.1 ml. Primary tumor outgrowth was monitored at two-day intervals by taking measurements of the tumor length (L) and width (W). Tumor volume was calculated as π LW 2 /6.
Spontaneous lung metastasis assay. B16 cells were harvested by trypsinization, suspended in PBS and counted. Cells (1.0x10 6 ) were injected subcutaneously at the back of anesthetized mice [Nembutal (pentobarbital sodium) 30 mg/kg] in a volume of 0.1 ml. Primary tumor outgrowth was monitored every 2 days by taking measurements of the tumor length (L) and width (W). Tumor volume was calculated as π LW 2 /6. For spontaneous metastasis assays, tumors were surgically resected when they reached >500 mm 3 . Three weeks after resection, the mice were sacrificed and their lungs were excised. The numbers of black lung metastatic nodules were counted under a dissecting microscope.
Invasion assay. Modified Boyden chambers with filter inserts (pore size of 8 μm) coated with Matrigel (BD Bioscience) in 24-well dishes were employed for invasion assays. NIH3T3 conditioned medium was added to the lower compartment of the chamber as the chemoattractant. Cells starved in DMEM containing 0.1% bovine serum albumin (DMEM-BSA) overnight were trypsinized briefly and collected, and then 500 μl cell suspension (2x10 5 cells/ml in DMEM-BSA) was added to upper compartment of the chamber and incubated at 37˚C in a humidified atmosphere with 5% CO 2 for 24 h. Cells on the upper surface of the membrane were removed with a cotton swab, and cells had migrated to the under surface of the membrane were fixed and stained with Diff-Quik (Sysmex International Reagents Co.) and counted phase-contrast microscope with a x20 objective lens. Numbers of cells in twelve randomly selected fields from triplicate chambers were counted.
Anti-Nd1-L antibody. Three rabbits were immunized with purified mouse Nd1-L produced in E. coli in Freund's complete adjuvant subcutaneously in their backs. After 2 boosts with purified Nd1-L in incomplete adjuvant, rabbits were bled.
Production of anti-mouse Nd1-L sera was checked by Western blot analysis using pre-immune sera as a negative control.
Western blotting. Cells were sonicated in lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 1% Triton-X, 1 mM EDTA, 1 mM sodium orthovanadate, 1 mM phenylmethylsulfonyl fluoride, 10 μg/ml aprotinin, and 10 μg/ml leupeptin). Proteins were separated by SDS-PAGE and were transferred to polyvinylidene difluoride membranes (Millipore). Membranes were blocked with non-fat dry milk (Yukijirushi) and were incubated with the following antibodies: mouse anti-Rho, mouse anti-Rac, mouse anti-Cdc42 (Upstate) or rabbit anti-Nd1-L antibody, followed by incubating with anti-rabbit (Jackson Immuno-Research Laboratories, West Grove, PA) or anti-mouse immunoglobulin antibody (Upstate). The filters were washed with TBS/0.5% Tween-20 and immunoreactive bands were visualized with ECL system (Amersham Pharmacia). Band images were scanned and densitometric analyses were performed using NIH Image, version 1.63.
Rho family pull-down assay. The Rho family pull-down assay was performed as described previously (25, 26) . Briefly, cells were plated in 10-cm dishes, serum-starved for 12 h, and lysed in 25 mM HEPES, pH 7.5, 150 mM NaCl, 1% NP40, 10 mM MgCl 2 , 1 mM EDTA, 1 mM sodium orthovanadate, 10 μg/ml leupeptin and 10 μg/ml aprotinin. One-tenth of the cell lysates were subjected to immunoblotting. The remaining cell lysate was mixed with 25 μg of bacterially expressed GST-rhotekin (murine amino acids 7-89, for RhoA-GTP) and 25 μg of bacterially expressed GST-PAK (human PAK-1 amino acids 67-150, for Rac1-GTP and Cdc42-GTP) bound to glutathione agarose (Upstate) and incubated at 4˚C with tumbling for 45-60 min. Beads were collected by centrifugation and washed three-times in 25 mM HEPES, pH 7.5, 150 mM NaCl, 1% NP40, 10 mM MgCl 2 , 1 mM EDTA, 1 mM sodium orthovanadate, 10 μg/ml leupeptin and 10 μg/ml aprotinin before addition of Laemmli buffer and analyzed by Western blotting with anti-RhoA clone55, anti-Rac1 and anti-Cdc42 antibodies (Upstate).
Statistical analysis. The data are presented as the mean ± SD. Fisher's exact probability test was used to compare data between two groups. Survival curves were obtained using the Kaplan-Meier method. All statistical analyses were carried out using the StatView 5.0 J program for Windows (SAS Institute, Cary, NC). P-values <0.05 were considered statistically significant.
Results

Reduction of Nd1-L expression in metastatic tumor nodules.
In order to examine whether Nd1-L is involved in tumor metastasis, we used murine metastatic colon tumor cell line Colon 26 to compare the expression of Nd1-L between parental cells and metastatic nodules. Two weeks after intravenous injection of the parental Colon 26 cells, metastatic nodules in lungs were isolated and expanded in vitro to examine the Nd1-L expression. Expression of Nd1-L protein reduced in all metastatic nodules from lungs compared to that of parental cells (Fig. 1) . This result suggests that Nd1-L is one of the key determinants of whether a tumor cell will be more or less invasive and metastatic. and B16 cells ( Fig. 2b ; BKD1 and BKD2). We also obtained Nd1-L over-expressing Colon 26 cells ( Fig. 2a ; CT1 and CT2) and B16 cells ( Fig. 2b ; BT1, BT2 and BT3). These cells were injected into tail vein of 6-week-old syngeneic mice and number of metastatic nodules in lungs was examined 2 weeks after inoculation. Over-expression of Nd1-L dramatically reduced the number of lung metastatic nodules while knock down of Nd1-L promoted the metastasis in both Colon 26 and B16 cells ( Fig. 2c and d respectively) . The size of each nodule did not differ among Nd1-L over-expression, knock down, and control groups (data not shown). The number of moribund mice injected with Colon 26 Nd1-L transfectants was significantly lower than that of mice injected with control Colon 26 cells (Fig. 2e) .
Although intravenous inoculation provides a convenient model in which to assay pulmonary metastases, its relevance to distant organ metastasis in animals and humans is limited. To determine the effect of Nd1-L expression on pulmonary metastasis in an orthotopic model, we inoculated B16 cells transfected either with pCR-2FL-Nd1-L vector (clone BT1 and BT2) or pCR-3.1 control vector into the back of syngeneic mice and tumor were removed after reaching >500 mm 3 . As shown in Table I , over-expression of Nd1-L suppressed spontaneous pulumonary metastasis of B16 melanoma cells. Table I . Lung metastasis after subcutaneous inoculation of B16 melanoma cells.
-------------------------------------------------Cell line
Lung metastasis % frequency metastasis
Nd1-L transfectant 2 (BT2) 2/8
-------------------------------------------------
In order to form orthotropic tumors, B16 cell population (a control cell line and two transfectant cell lines) were inoculated subcutaneously into the back of each mouse and tumors were removed after reaching >500 mm 3 . Mice were sacrificed and lung metastasis was examined 3 weeks after removal of the primary tumor.
The over-expression or knock down of Nd1-L in Colon 26 or B16 cells did not alter proliferation rates of these cells in vivo (Fig. 2f and g ). These data rule out the possibility that the effects of Nd1-L on tumor metastatic ability were attributable to the different proliferation rates. Thus, increased expression of Nd1-L significantly decreased pulmonary metastasis, in both experimental and spontaneous lung metastasis models.
To examine whether effect of Nd1-L on metastatic ability is specific for lung metastasis, we used intra-splenic injection method to analyze liver metastasis, which is another favorable metastatic lesion of colon cancer and melanoma. As shown in Fig. 3 , over-expression of Nd1-L suppressed liver metastasis while knock down of Nd1-L promoted that in both Colon 26 ( Fig. 3a) and B16 (Fig. 3b) cells. Thus, the effect of Nd1-L on metastatic ability is not specific for lung metastasis. Colon 26 and B16 cells. Since migratory and invasive properties of cells are important factors that determine cancer cell metastatic ability, it is necessary to examine whether Nd1-L would contribute to the motility and invasiveness of these cells. Colon 26 cells and B16 cells stably over-expressing Nd1-L or transfected with Nd1-L siRNA were subjected either to migration assays or to Matrigel invasion assays (Fig. 4) . As shown in the figures, over-expression of Nd1-L in both Colon 26 ( Fig. 4a; CT1 and CT2) and B16 cells ( Fig. 4b; BT1 and BT2 ) suppressed migration through a membrane. Invasion capacity through Matrigel was also decreased in these tumor cell lines transfected with Nd1-L ( Fig. 4c and d) . Furthermore, knock down of Nd1-L by siRNA increased the number of cells that invade through Matrigel in both Colon 26 (Fig. 4c) and B16 (Fig. 4d) cells. Thus, the amount of Nd1-L in these cancer cell lines inversely correlated with the migration and invasive capacities. after the stimulation, Rho activity increased at maximum level and then declined. This increase of Rho activation was suppressed in NIH3T3 cells over-expressed with Nd1-L was initially of weaker magnitude ( Fig. 6a and b) . In contrast, initial Rho activation was augmented and high activity was sustained up to 20 min in NIH3T3 cells transfected with pBAsi-Nd1-L. These data demonstrate that Rho activation by LPA stimulation was regulated in a Nd1-L-dependent manner and there is Nd1-L-dependent down-regulation of Rho following activation by LPA. Rac and cdc42 induce reorganization of actin cytoskeleton at leading edge of the cell. We also measured Rac and cdc42 activity in serum starved NIH3T3 cells after stimulation with PDGF-BB and LPA respectively. Both Rac and cdc42 activation were augmented in pBAsi-Nd1-L transfected cells. In contrast, over-expression of Nd1-L suppressed Rac and cdc42 activation (Fig. 6c-f) . Thus, Nd1-L negatively regulates Rho family GTPase activation, which may result in suppression of invasion and migration activity in cancer cells.
Nd1-L regulates motility and invasion in
Nd1-L down-regulates growth factor-induced
Discussion
The majority of cancer deaths result from tumor metastases rather than primary tumors. The biochemical mechanisms that regulate invasion and metastasis remain incompletely defined. In this report, we showed that over-expression of BTB-kelch protein Nd1-L suppressed cancer cell metastasis and prolonged survival of tumor bearing mice in an animal model. The metastatic process consists of multiple steps: i) dissociation of tumor cells from the primary site with a concomitant loss of cell to cell and cell to extracellular matrix (ECM) adhesions; ii) tumor cell adhesion to and subsequent local digestion of basement membrane; iii) retraction of endothelial cells and subsequent intravasation; iv) survival within the vasculature; v) extravasation from vasculature at a distant site, and vi) growth in a foreign or ectopic organ environment. Considerable evidence exists to support the concept that each discrete step of metastasis is regulated by transient or permanent changes at the DNA, mRNA, and/or protein levels for different genes (27) . Much attention has been paid to the interaction of cell to cell and cell to ECM adhesion on cancer metastatic capacity (28) . However, over-expression of Nd1-L in cancer cells did not alter the expression of adhesion molecules such as integrin and cadherin family protein (data not shown). Tumor cell migration is an important step for establishment of cancer metastasis. Since over-expression of Nd1-L in Colon 26 and B16 cells reduced migration and invasion capacities in vitro, Nd1-L might control the intravasation and extravasation steps in the metastatic process. It is of interest that most of the lung metastatic nodules of intravenously injected Colon 26 cells expressed less Nd1-L protein than parental cells (Fig. 1) . It is possible that reduction of Nd1-L protein is one of the critical factors for establishment of cancer metastasis.
Nd1-L might modulate activation of Rho family protein to suppress invasion and metastasis. Rho family GTPases, including RhoA, RhoC, Rac, and cdc42, are critical regulators of actin organization associated with cell motility, cell cycle progression, and gene expression (29) . There is considerable evidence that aberrant Rho GTPase activation promotes tumor cell growth, invasion, and metastasis (30) . We show here that Nd1-L suppresses the activation of the Rho family GTPase RhoA, Rac and cdc42, whereas, siRNA mediated knockdown of Nd1-L in NIH3T3 cells promote the activation of the Rho family GTPase. These observations strongly imply that Rho family GTPase acts downstream of Nd1-L. Although we have shown an important functional connection between Nd1-L and Rho family proteins, the nature of this connection is unclear. Nd1-L is recognized as an actin binding protein that belongs to the kelch family proteins. Pleiotrophic function of kelch family proteins other than actin binding has been demonstrated. Whether Nd1-L directly regulates Rho GEFs and how remains to be determined. Further biochemical characterization is required to elucidate the function of Nd1-L in regulation of Rho family protein and cytoskeletal organization.
Several genes responsible for metastasis have been identified. It is proposed that metastasis genes should be classified in two groups. First group of genes expressed in both primary and metastatic lesions. These genes confer both tumorigenicity of primary tumor and basal metastagenicity. The second set of genes act mainly as virulence genes that may allow tumors to aggressively invade, colonize and grow in the metastatic lesions without markedly contributing to primary tumor growth (22) . Our result suggested that reduction of Nd1-L in tumor cells was one of the critical steps for the establishment of metastasis.
In conclusion, our results demonstrated that Nd1-L was able to affect tumor cell motility and invasion that contribute to the establishment of cancer metastasis via Rho family protein dependent mechanisms. The findings that Nd1-L over-expression can inhibit tumor cell migration and suppress metastasis provide clinical validation, potential prognostic tools and possible target for cancer treatment.
